
Loading, please wait...

Loading, please wait...

AI in healthcare must be a collaborative effort between tech innovators and medical professionals. Dr. VK Paul from Niti Aayog recently highlighted this necessity at the AI Impact Summit in New Delhi. He argued that validation is the only way to ensure these tools are safe for public use. Therefore, clinical expertise must guide every stage of the development process. Consequently, innovators can avoid the pitfalls of developing technology in isolation.
Innovators should not work in silos. Instead, they must partner with clinicians, radiologists, and public health experts. This partnership ensures that products meet specific medical needs. Furthermore, validation metrics like sensitivity and specificity remain vital for measuring performance. Dr. Paul noted that the government wishes to build a culture of responsible adoption. However, this progress requires alignment with existing legal and regulatory frameworks. Moreover, the goal is to provide oversight that protects patient safety.
He further emphasized that any validated tool would be absorbed into the national health system. This process follows a rigorous health technology assessment. Consequently, such tools will eventually become public goods for all citizens. This move aims to democratize high-quality care across rural and urban divides. Hence, clinical researchers and trial experts must be involved from the start.
Dr. Harsh Mahajan, a renowned radiologist, echoed these sentiments during the panel discussion. He stated that AI in healthcare can be highly beneficial only if used ethically. Crucially, these tools must remain under the supervision of trained professionals. He warned against the public using platforms like ChatGPT for self-diagnosis, citing potential clinical risks. Similarly, modern imaging equipment already incorporates AI to reduce radiation and improve scan quality. However, human judgment remains irreplaceable in interpreting complex data.
Nico Schiettekatte from the Netherlands Embassy added that technology must solve real problems. We must evaluate whether these interventions actually improve patient recovery outcomes. Therefore, the focus should shift from mere experimentation to large-scale implementation. Finally, ensuring that AI serves humanity is the ultimate goal of these foundational shifts.
Q1: Why is clinical co-creation vital for AI in healthcare?
Innovators often lack clinical context. Therefore, partnering with doctors ensures tools are medically sound, ethically developed, and meet strict regulatory standards.
Q2: What role does Niti Aayog play in adopting AI tools?
Niti Aayog assesses validated tools through health technology assessments. Consequently, they integrate these tools into the public health system as scalable public goods.
Q3: Is it safe for patients to use general AI for self-diagnosis?
No, experts warn that self-diagnosis using tools like ChatGPT is risky. Professional medical supervision is necessary to ensure patient safety and accurate diagnosis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Niti Aayog’s Dr. VK Paul urges innovators to co-create AI with medical experts, ensuring clinical validation and regulatory compliance for safe health adopt...
8 months ago

A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today